Further analysis of various serum tumor markers demonstrated that the detection of CD45+EpCAM+ cells in the circulating blood has a higher specificity for the diagnosis of lung cancer than commonly used serological auxiliary tests. This evidence concerns the gene EPCAM and lung carcinoma.